JAMA Psychiatry

Papers
(The H4-Index of JAMA Psychiatry is 67. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
Combination Antidepressant Therapy vs Monotherapy—Further Considerations1054
Potential Limitations for Assessing Adverse Posttraumatic Neuropsychiatric Sequelae With Wrist-Wearable Device and Self-report Survey585
Assumptions and Limitations of the Synthetic Control Method497
Error in Results349
Further Considerations on Early Intervention for Borderline Personality Disorder—Reply289
JAMA Psychiatry264
JAMA Psychiatry249
Integrating Financing Variables Into Behavioral Health Policy Implementation Research240
An Opportunity to Advance Cannabis Science—DEA Rescheduling222
JAMA Psychiatry215
The Reliability of Traumatic and Adverse Experiences199
Polygenic Contributions to Lithium Augmentation Outcomes in Unipolar Depression192
Effect of Culturally Tailored, Internet-Delivered Cognitive Behavioral Therapy for Insomnia in Black Women168
Diagnosing and Treating ADHD in Adults160
Patients Use AI—Clinicians Should Ask How155
Overmystifying the Psychedelic Experience154
Magnetic Seizure Therapy vs Electroconvulsive Therapy for Major Depressive Episode147
TikTok Challenges—Unintentional Injuries vs Suicide Attempts146
Error in Abstract135
Left Ventrolateral Prefrontal Cortical Activity During Reward Expectancy and Mania Risk134
Social Vulnerability and Prevalence and Treatment for Mental Health and Substance Use Disorders133
Managerial and Organizational Challenges in the Age of AI133
Neighborhood Disadvantage and Autism Spectrum Disorder in a Population With Health Insurance132
Issues in Clinical Trial Design—Lessons From the FDA’s Rejection of MDMA131
Associations Between Objective and Subjective Experiences of Childhood Maltreatment and the Course of Emotional Disorders in Adulthood130
Brief Cognitive Behavioral Therapy for Suicidal Military Personnel and Veterans129
Prenatal Adversities and Risk of Persistent Youth Psychopathology and Altered Cortical Thinning128
Accelerated Theta-Burst Stimulation for Treatment-Resistant Depression125
Percentage of Heavy Drinking Days Following Psilocybin-Assisted Psychotherapy vs Placebo in the Treatment of Adult Patients With Alcohol Use Disorder120
Consistency of Delusion Themes Across First and Subsequent Episodes of Psychosis120
Errors in Figures 1 and 2114
JAMA Network Call for Papers on Health and the 2024 US Election112
JAMA Psychiatry108
Error in the Caption of Figures 2, 3, 4, and 5 and in Supplement 1106
Hyperalgesia in Patients With a History of Opioid Use Disorder104
Error in Byline104
Living Alone and Drug Overdose Deaths in the US98
Risk for Mood, Anxiety, and Psychotic Disorders in Individuals at High and Low Genetic Liability for Bipolar Disorder and Major Depression95
Association of Frailty With Risk of Suicide Attempt in a National Cohort of US Veterans Aged 65 Years or Older93
US Veterans Affairs and Department of Defense 2023 Clinical Guideline for PTSD—Devolving Not Evolving93
Addiction Medicine Physicians and Medicinal Cannabinoids91
Mental Health Impairment and Outpatient Mental Health Care of US Children and Adolescents90
Evaluation of Post–COVID-19 Cognitive Dysfunction: Recommendations for Researchers90
Efficacy of Augmentation of Cognitive Behavioral Therapy With Transcranial Direct Current Stimulation for Depression88
The Role of Energy Homeostasis in Depression Pathophysiology and Its Heterogeneity88
Searching the Brain for the Cause of Psychosis88
Perinatal Mental Health Outcomes Following Natural Disasters87
Serotonin 4 Receptor Brain Binding in Major Depressive Disorder and Association With Memory Dysfunction87
Effect of a Tobacco Cessation Intervention Incorporating Weight Management for Adults With Serious Mental Illness85
Associating Violence With Schizophrenia—Risks and Biases—Reply83
COVID-19 and Mental Health in Young People—Causality or Co-occurrence?83
JAMA Psychiatry—The Year in Review, 202180
JAMA Psychiatry79
Etiologic Studies of Premenstrual Disorders Require Prospective Confirmation of Affective Cyclicity79
Combination Antidepressant Therapy vs Monotherapy—Further Considerations77
Limitations for Assessing Optimism and Physical Functioning in Women—Reply77
JAMA Psychiatry76
Measures of General Intelligence and Risk for Alcohol Use Disorder75
Does Vaccination Really Mitigate Psychiatric Implications of COVID-19?—Reply74
Physician Suicide and Associated Features—What Defines a Physician?73
Comorbidity and Coaggregation of Major Depressive Disorder and Bipolar Disorder and Cannabis Use Disorder in a Controlled Family Study71
Metabolomic Biomarker Signatures for Bipolar and Unipolar Depression69
Neurobiological, Psychosocial, and Behavioral Mechanisms Mediating Associations Between Physical Activity and Psychiatric Symptoms in Youth in the Netherlands68
Adjuvant Psychotherapies to Prevent Relapse in Bipolar Disorder68
Methadone-Involved Overdose Deaths in the US Before and After Federal Policy Changes Expanding Take-Home Methadone Doses From Opioid Treatment Programs68
Genetic Liabilities Differentiating Bipolar Disorder, Schizophrenia, and Major Depressive Disorder, and Phenotypic Heterogeneity in Bipolar Disorder68
Sweetened Beverages and Incident All-Cause Dementia Among Older Adults67
0.1571409702301